Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Chimia|October 29, 2020
Discovery of Small Molecule Drugs Targeting the Biogenesis of microRNA-155 for the Treatment of Systemic Lupus ErythematosusKamal Azzaoui, Marcel Blommers, Marjo Götte, et al.Journal of Biomolecular Screening|December 20, 2005
A chemoinformatics analysis of hit lists obtained from high-throughput affinity-selection screeningNathan Brown, Hartmut Zehender, Kamal Azzaoui, et al.Future Medicinal Chemistry|March 24, 2011
In vitro safety pharmacology profiling: what else beyond hERG?Jacques Hamon, Steven Whitebread, Valerie Techer-Etienne, et al.Organic & Biomolecular Chemistry|November 10, 2004
Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structuresJérôme Hert, Peter Willett, David J Wilton, et al.Journal of Medicinal Chemistry|October 28, 2005
Enhancing the effectiveness of similarity-based virtual screening using nearest-neighbor informationJérôme Hert, Peter Willett, David J Wilton, et al.Journal of Chemical Information and Computer Sciences|May 25, 2004
Comparison of fingerprint-based methods for virtual screening using multiple bioactive reference structuresJérôme Hert, Peter Willett, David J Wilton, et al.Journal of Chemical Information and Modeling|March 28, 2006
New methods for ligand-based virtual screening: use of data fusion and machine learning to enhance the effectiveness of similarity searchingJérôme Hert, Peter Willett, David J Wilton, et al.Chemmedchem|May 12, 2007
Modeling promiscuity based on in vitro safety pharmacology profiling dataKamal Azzaoui, Jacques Hamon, Bernard Faller, et al.Expert Opinion on Drug Metabolism & Toxicology|November 28, 2006
High-throughput in vitro profiling assays: lessons learnt from experiences at NovartisBernard Faller, Jianling Wang, Alfred Zimmerlin, et al.Chemmedchem|May 5, 2007
Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structureAndreas Bender, Josef Scheiber, Meir Glick, et al.Pageof 3